These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany. Riechmann J, Strzelczyk A, Reese JP, Boor R, Stephani U, Langner C, Neubauer BA, Oberman B, Philippi H, Rochel M, Seeger J, Seipelt P, Oertel WH, Dodel R, Rosenow F, Hamer HM, EpiPaed Study Group. Epilepsia; 2015 Sep; 56(9):1388-97. PubMed ID: 26235849 [Abstract] [Full Text] [Related]
8. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam. Strzelczyk A, Schubert-Bast S, Reese JP, Rosenow F, Stephani U, Boor R. Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467 [Abstract] [Full Text] [Related]
13. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China. Hong Z, Qu B, Wu XT, Yang TH, Zhang Q, Zhou D. Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782 [Abstract] [Full Text] [Related]
14. Evaluation of health-care utilization among adult patients with epilepsy in Germany. Strzelczyk A, Nickolay T, Bauer S, Haag A, Knake S, Oertel WH, Reif PS, Rosenow F, Reese JP, Dodel R, Hamer HM. Epilepsy Behav; 2012 Apr; 23(4):451-7. PubMed ID: 22381385 [Abstract] [Full Text] [Related]
15. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Davis KL, Candrilli SD, Edin HM. Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549 [Abstract] [Full Text] [Related]
19. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy. Luoni C, Canevini MP, Capovilla G, De Sarro G, Galimberti CA, Gatti G, Guerrini R, La Neve A, Mazzucchelli I, Rosati E, Specchio LM, Striano S, Tinuper P, Perucca E. Epilepsia; 2015 Jul; 56(7):1162-73. PubMed ID: 26046371 [Abstract] [Full Text] [Related]